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Enhancing cognitive abilities has become a fascinating scientific challenge, recently driven 
by the interest in preventing age-related cognitive decline and sustaining normal cogni-
tive performance in response to cognitively demanding environments. In recent years, 
cocoa and cocoa-derived products, as a rich source of flavonoids, mainly the flavanols 
sub-class, have been clearly shown to exert cardiovascular benefits. More recently, 
neuromodulation and neuroprotective actions have been also suggested. Here, we dis-
cuss human studies specifically aimed at investigating the effects of acute and chronic 
administration of cocoa flavanols on different cognitive domains, such as executive func-
tions, attention and memory. Through a variety of direct and indirect biological actions, 
in part still speculative, cocoa and cocoa-derived food have been suggested to possess 
the potential to counteract cognitive decline and sustain cognitive abilities, particularly 
among patients at risk. Although still at a preliminary stage, research investigating the 
relations between cocoa and cognition shows dose-dependent improvements in general 
cognition, attention, processing speed, and working memory. Moreover, cocoa flavanols 
administration could also enhance normal cognitive functioning and exert a protective 
role on cognitive performance and cardiovascular function specifically impaired by sleep 
loss, in healthy subjects. Together, these findings converge at pointing to cocoa as a new 
interesting nutraceutical tool to protect human cognition and counteract different types 
of cognitive decline, thus encouraging further investigations. Future research should 
include complex experimental designs combining neuroimaging techniques with physi-
ological and behavioral measures to better elucidate cocoa neuromodulatory properties 
and directly compare immediate versus long-lasting cognitive effects.
Keywords: chocolate, flavanols, neuroprotection, cognitive function, cardiovascular function
Abbreviations: BOLD, blood oxygenation level-dependent; BDNF, brain-derived neurotrophic factor; CBF, cerebral blood 
flow; ERK, extracellular signal-regulated kinase; LTP, long-term potentiation; MAPK, mitogen-activated protein kinase; NIRS, 
near-infrared spectroscopy; NO, nitric oxide; PI3-kinase/Akt, phosphoinositide 3-kinase; SSVEP, steady-state visually evoked 
potentials.
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inTRODUCTiOn
With the increase in general population aging, age-related cog-
nitive decline has progressively become a major public health 
issue. Consequently, enhancing cognitive resources came to be 
a priority scientific challenge, mainly driven by the need to detect 
preventive agents for cognitive decline and dementia. At the same 
time, immediate cognitive enhancement is often desirable in cog-
nitively demanding environments. Stimulants such as caffeine are 
indeed commonly used to sustain cognitive performance during 
periods of fatigue and prolonged wakefulness (1).
In the last years, the field of nutraceuticals and functional 
food has developed along with the interest in the potential 
modulatory effects of food constituents on human health. In this 
context, there has been increasing interest in the biological effects 
of flavonoids, a class of polyphenolic compounds, as potential 
nutraceuticals with several beneficial biological actions, includ-
ing cardioprotection, neuroprotection, and neuromodulation. 
Particularly, cocoa bean has been recognized as a rich source of 
flavonoids, mainly the flavanols subclass in the form of epicat-
echin and catechin (2).
Chocolate also contains other functional ingredients, such as 
the methylxanthine caffeine and theobromine, with the potential 
to influence neurocognitive function. However, relative to total 
flavanols content, caffeine and theobromine concentrations in 
cocoa and chocolate have been considered lower than those 
required to exert significant pharmacological actions (3).
Epidemiologic studies suggest that a regular intake of fla-
vonoids could be associated with better cognitive function (4), 
decreased risk of dementia (5) and cognitive decline (6), lower 
prevalence of cognitive impairment (7), better cognitive evolution 
over a 10-year period (8), and better dose-dependent cognitive 
performance in normal aging (9).
The specific mechanisms of action of flavonoids responsible for 
cognitive protection and modulation are not entirely elucidated. 
Nevertheless, increasing evidence supports the notion that cocoa 
and chocolate consumption provides several health benefits, 
including neurocognitive enhancement and neuroprotective 
effects. In this brief review, we discuss human studies specifically 
aimed at investigating the effects of acute and chronic administra-
tion of cocoa flavanols on cognition.
enHAnCinG COGniTiOn wiTH COCOA 
FLAvOnOiDS: DiReCT veRSUS inDiReCT 
MeCHAniSMS OF ACTiOn
The beneficial effects of polyphenolic compounds have been 
first attributed to their ability to exert antioxidant actions (10). 
However, due to the very low concentration of flavonoids detect-
able in the brain, it is unlikely that direct antioxidant action can 
entirely account for cognitive effects in vivo. Instead, flavonoids’ 
neurobiological effects are now believed to be mediated by a range 
of actions involving the ability to protect vulnerable neurons, 
enhance neuronal function, and stimulate regeneration via inter-
action with neuronal intracellular signaling pathways involved 
in neuronal survival and differentiation, long-term potentiation 
(LTP), and memory (11).
Flavonoids can counteract neuronal injury underlying neuro-
degenerative diseases such as Parkinson and Alzheimer diseases 
through their interaction with signaling proteins important in 
the pro-survival pathways (12). Interestingly, flavonoids and their 
metabolites cross the blood–brain barrier and have been local-
ized in the brain, particularly in areas crucial for learning and 
memory such as hippocampus, cerebral cortex, cerebellum, and 
striatum (13–15). These structures are particularly vulnerable 
to the effects of aging and neurodegeneration, suggesting that 
flavonoids could exert direct neuroprotective effects (16). Direct 
interactions within several cellular signaling pathways have been 
described, such as mitogen-activated protein kinase, extracellular 
signal-regulated kinase, and phosphoinositide 3-kinase (PI3-
kinase/Akt) signaling cascades (17), that are crucially involved 
in triggering gene expression and protein synthesis for LTP (18). 
In memory-related areas such as the hippocampus, flavonoids 
promote the expression of brain-derived neurotrophic factor 
(BDNF), that is crucial to adult neurogenesis, synaptic growth, 
and neuronal survival (19). Increasing evidence from animal 
models indicates that flavonoids can promote cognitive benefits 
through their ability to directly interact with the cellular and 
molecular architecture involved in memory function (2, 11, 12). 
To date, however, it is still not entirely clear whether and to what 
extent these direct biological actions also extend to the human 
brain.
Flavonoids could also display their neurocognitive effects 
indirectly, through their capability of inducing cardiovascular 
actions. In this regard, cardiovascular benefits of cocoa and 
chocolate consumption are now well established and include 
endothelium-dependent vasodilation, which contributes to the 
maintenance of normal blood flow, reduced platelet aggregation, 
and blood pressure improvement (20–26).
Importantly, flavanols such as epicatechin can improve 
endothelial function by increasing the nitric oxide (NO) bioavail-
ability, a key regulator of vascular function, leading to improve-
ments in vascular tone and blood pressure regulation (27, 28). 
These peripheral vascular changes may also extend to brain 
perfusion, leading to a more efficient cerebrovascular coupling 
during neuronal activation, which is considered crucial for the 
functional and structural integrity of the brain. Moreover, as 
increased cerebrovascular function promotes adult neurogenesis 
in the hippocampus (29), flavonoid-mediated vascular changes 
could be additionally relevant for memory function.
Coherently, increasing evidence highlights the potential 
of cocoa flavanols to influence cognitive abilities interacting 
with the cerebrovascular system. Flavanol-rich cocoa has been 
shown to significantly increase cerebral blood flow (CBF) 1–2 h 
post-intervention in humans (30–32), suggesting that flavanols’ 
indirect, vasodilatatory actions could account for acute cognitive 
enhancement following a single administration (16). Conversely, 
cognitive benefits associated with long-term flavonoids intake are 
more likely to involve morphological changes induced by direct 
actions on neuronal signaling. However, indirect mechanisms of 
action can also contribute to long-term neuroprotective effects, as 
increases in NO levels can further impact on brain vasculariza-
tion over time by promoting angiogenesis, thus resulting in better 
cerebrovascular communication.
TAbLe 1 | Summary of the studies examining the effects of daily administration of cocoa flavanols on cognitive performance.
Reference Participants Flavanols amount Cognitive measures Principal findings
Francis et al. (31) 16 subjects 
(all females; 
18–30 years)
Cocoa drinks containing 172 
and 13 mg flavanols daily over a 
5-day period
Task switching paradigm Increased BOLD signal in response to the task 
switching paradigm after the higher flavanol drink, 
with no significant behavioral effect
Crews et al. (34) 101 subjects 
(41 males, 60 
females; mean age: 
69 years)
Chocolate bar containing 
397 mg flavanols, chocolate 
drink containing 357 mg 
flavanols, or similar placebo
Selective Reminding Test, 
Stroop Test, Trail Making 
Test, Wechsler Adult 
Intelligence Scale-III (Digit 
Symbol-Coding Subtest), 
Wechsler Memory Scale-
III (Faces I and Faces II 
Subtests)
No differences in cognitive performance between 
placebo and polyphenol groups
Camfield et al. (35) 63 subjects 
(40–65 years)
Cocoa drinks containing 
500, 250, and 0 mg flavanols 
(placebo) over a 30-day period
Spatial Working Memory Test SSVEP changes indicating improved working 
memory function after flavanol treatment, with no 
significant behavioral effect
Desideri et al. (36) 90 subjects with 
Mild Cognitive 
Impairment (43 
males, 47 females; 
64–82 years)
Cocoa drinks containing 993, 
520, or 48 mg (low-flavanol) 
flavanols daily over an 8-week 
period
Mini-Mental State 
Examination, Trail Making 
Test (A–B), Verbal Fluency 
Test
Improvements in blood pressure, insulin resistance 
and Tail Making Test (A–B) performance for high and 
intermediate flavanol groups compared to the low-
flavanol group. Improved verbal fluency performance 
in the high-flavanol group
Sorond et al. (37) 60 subjects with 
vascular risk factors 
(29 males, 31 
females; mean age: 
72.9 years) 
Cocoa drinks containing 609 or 
13 mg (flavanol-poor) flavanols 
daily over a 30-day period
Mini-Mental State 
Examination, Trail Making 
Test (A–B)
Improvements in neurovascular coupling and Trial 
Making Test B performance for the flavanols group, 
only in those with impaired neurovascular coupling 
at baseline
Brickman et al. (38) 37 subjects (13 
males, 24 females; 
50–69 years)
Cocoa supplement containing 
900 or 10 mg (low-flavanol) 
flavanols daily over a 3-month 
period
Modified Benton Task 
(dentate gyrus-dependent 
memory task)
Correlation between increased cerebral blood 
volume in the dentate gyrus and improvements in 
the Modified Benton Task performance in the high-
flavanol group
Mastroiacovo et al. (39) 90 subjects (37 
males, 53 females; 
65–85 years)
Cocoa drinks containing 993, 
520, or 48 mg (low-flavanol) 
flavanols daily over an 8-week 
period
Mini-Mental State 
Examination, Trail Making 
Test (A–B), Verbal Fluency 
Test
Improvements in blood pressure, insulin resistance 
and Tail Making Test (A–B) performance for high and 
intermediate flavanol groups in comparison to low-
flavanol group. Improved verbal fluency performance 
among all treatment groups
Neshatdoust et al. (40) 40 subjects (22 
males, 18 females; 
62–75 years, mean 
age: 68.3 years)
Cocoa drinks containing 494 
and 23 mg (low-flavanol) 
flavanols daily over a 28-day 
period
Several cognitive tasks 
measuring executive 
functions, episodic memory, 
working memory, spatial 
memory, implicit memory, 
attention and processing 
speed
Higher BDNF serum levels and improvements in 
global cognition scores following high-flavanol 
treatment
BDNF, brain-derived neurotrophic factor; BOLD, blood oxygenation level-dependent; SSVEP, steady-state visually evoked potentials.
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eFFeCTS OF COCOA FLAvAnOLS DAiLY 
inTAKe On COGniTiOn: eviDenCe 
FROM CHROniC inveSTiGATiOnS
In line with the evidence suggesting a favorable association 
between flavonoids’ regular consumption and cognitive perfor-
mance in elderly subjects (33), chronic and sub-chronic cognitive 
effects of cocoa flavanols administration have been addressed in 
normal aging and clinical populations (see Table 1).
In this respect, the daily consumption of flavanol-rich cocoa 
drink has been showed to positively affect cognition, leading to 
improvements in cognitive performance both in older adults 
with early memory decline (36) and in cognitively intact elderly 
subjects (39). Specifically, compared to the low-flavanol condition 
(48  mg), the chronic administration of intermediate (520  mg) 
and high (993  mg) cocoa flavanols content over an 8-week 
period was associated to improvements in processing speed, 
executive function, and working memory in subjects with mild 
cognitive impairment. At higher cocoa flavanols concentrations, 
significant improvements were also evident in a verbal fluency 
task. Interestingly, such cognitive beneficial effects were paral-
leled by improvements in blood pressure and insulin resistance, 
suggesting a role of endothelial function and glucose sensitivity 
in modulating cognitive function in these patients (36). More 
recently, similar findings were replicated in healthy aged par-
ticipants. Subjects in the intermediate and high cocoa flavanols 
4Socci et al. Cocoa and Cognition
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groups, after a daily consumption over an 8-week period, showed 
better performance in several cognitive domains compared to 
those in the low-flavanol group (39).
By contrast, in healthy older adults a 6-week cocoa flavanols 
intervention showed no significant effects on cognitive and car-
diovascular outcomes (34). In this study, however, participants 
were administered chocolate bar or beverage containing 397 or 
357 mg flavanols, respectively; insufficient flavanols content may 
therefore account for the negative finding.
In middle-aged (40–65) subjects, Camfield et al. (35) inves-
tigated the chronic (30-day intake) neurocognitive effects of 
250 and 500 mg cocoa flavanols administration using a spatial 
working memory task and steady-state visually evoked potentials 
(SSVEP). Compared to placebo, participants receiving cocoa 
flavanols treatment showed changes in SSVEP average amplitude 
and phase across several posterior parietal and centro-frontal 
sites that indicated an increased neural efficiency in response 
to the working memory task. Hence, cocoa flavanols long-term 
intake could effectively improve cognition trough increased neu-
ral efficiency, although, in this healthy population, the observed 
changes in brain activation were not paralleled by concomitant 
improvements in spatial working memory accuracy. Similarly, 
a sub-chronic (5  days) daily intake of 172  mg cocoa flavanols 
was associated, in healthy young subjects, to increased blood 
oxygenation level-dependent signal in various brain regions in 
response to an attention switching task, without any behavioral 
effect (31).
It has been proposed that cocoa long-term cognitive protec-
tion could particularly affect populations at risk. In this regard, 
Sorond et al. (37) evaluated the effect of flavanol-rich cocoa on 
neurovascular coupling in older subjects with vascular risk fac-
tors. In patients with impaired cerebrovascular coupling at base-
line, cocoa administration was associated with improvements in 
cerebrovascular function both acutely and after a 30-day period. 
Moreover, chronic flavanols intake also resulted in improve-
ments in cognitive flexibility. Conversely, no significant effects of 
cocoa administration on neurovascular coupling and cognitive 
performance were observed in those with intact cerebrovascular 
functions (37).
Besides improving CBF and CBF velocity after daily intake 
(41, 42), cocoa flavanols could also specifically affect cerebral 
blood volume in memory-related brain areas (38). Using high-
resolution functional magnetic resonance imaging, a 3-month 
intervention with 900-mg cocoa flavanols resulted in increased 
cerebral blood volume in the dentate gyrus of the hippocampus, a 
structure particularly affected by aging and potentially implicated 
in memory decline. Moreover, the increase in cerebral blood vol-
ume was highly correlated with improvements in performance in 
a dentate gyrus-dependent memory task. Cocoa flavanols regular 
intake could therefore improve human dentate gyrus function 
through global increase in blood flow or a more selective increase 
in capillary density.
More recently, Neshatdoust et  al. (40) investigated the link 
between cognitive performance and BDNF serum levels in 
older participants following cocoa flavanols chronic adminis-
tration over 12  weeks. Results showed that, in comparison to 
a low-flavanol control (23 mg total flavanols), the daily intake 
of a high-flavanol cocoa drink (494  mg total flavanols) was 
associated with higher BDNF serum levels and improvements 
in global cognition scores. Therefore, changes in serum BDNF 
levels induced by cocoa flavanols could additionally underpin 
the beneficial effect of chronic cocoa flavanols intake on cogni-
tive functions.
Collectively, these findings seem to support quite consolidated 
epidemiological evidence indicating that regular cocoa flavanols 
intake possesses the potential to protect human cognition, 
particularly in aged populations (33). As suggested (43), cocoa 
flavanols long-term beneficial effects on cognition could also pos-
sibly explain the correlation between country levels of chocolate 
consumption and Nobel Prizes per capita.
ACUTe eFFeCTS OF COCOA FLAvAnOLS 
inTAKe On COGniTiOn
Only few randomized controlled trials have investigated the 
possibility that human cognitive function may be improved fol-
lowing acute cocoa consumption, within 6 h post-ingestion (see 
Table 2).
In a double-blind crossover study, 30 healthy adults were 
administered chocolate drinks containing 520 and 994  mg fla-
vanols and 46 mg matched control, with a 3-day washout between 
sessions (44). Cognitive assessment, designed to be cognitively 
fatiguing, consisted in a 10-min task battery administered in six 
consecutive repetitions, including a serial subtraction task and 
a rapid visual information processing task. Results showed that, 
compared to control, both 520 and 994 mg cocoa flavanols doses 
significantly improved working memory performance on serial 
subtractions.
Using a similar acute intervention, Field et al. (45) found that 
2  ho after a 773-mg cocoa flavanols supplementation, young 
participants showed enhanced performance on the accuracy 
measure of a spatial working memory task, as well as perfor-
mance improvements on a choice reaction time task. Also, visual 
function was improved, with better visual contrast sensitivity and 
time to detect motion direction (45).
By contrast, Pase et al. (46) failed to demonstrate any acute 
effect of 500 mg cocoa flavanols administration on cognition in 
older adults. Cognitive assessment included measures of mem-
ory and attention. However, as a limitation, participants had a 
standardized lunch break before testing session; it is therefore 
possible that flavonoids effects were masked by post-prandial 
factors (46).
Immediate cognitive enhancement induced by high-flavanol 
cocoa is generally supposed to be mediated by the capability 
of their metabolites to promote crucial changes in peripheral 
and central blood flow. Some investigations therefore included 
behavioral and cardiovascular measures to explore the associa-
tion between acute post-intervention cognitive enhancement and 
changes in peripheral and central blood perfusion. In this respect, 
Massee et al. (47) showed improvements in a serial subtraction 
task after the acute administration, in healthy subjects, of a cocoa 
bar containing 250  mg of flavanols. However, this study failed 
to demonstrate significant concomitant cardiovascular improve-
ments after treatment. Conversely, a pilot study in healthy young 
TAbLe 2 | Summary of the studies examining the effects of acute administration of cocoa flavanols on cognitive performance.
Reference Participants Flavanols amount Cognitive measures Principal findings
Scholey et al. (44) 30 subjects (13 
males, 17 females; 
18–35 years)
Dairy based cocoa drinks 
containing 994, 520, and 
46 mg flavanols (control)
Rapid Visual Information 
Processing Task, Serial Threes 
Subtraction, Serial Sevens 
Subtraction
Improvements in Serial Threes performance following 
994 and 520 mg flavanols compared to 46 mg. 
Improved visual information processing performance 
after 994 mg flavanols
Field et al. (45) 30 subjects (8 
males, 22 females; 
18–25 years)
Dark chocolate containing 
773 mg flavanols and white 
chocolate (control)
Choice Reaction Time, Visual 
Spatial Working Memory Test
Improvements in spatial working memory performance 
and choice reaction time in the flavanol condition
Pase et al. (46) 71 subjects 
(40–65 years; 34% 
males)
Chocolate drinks containing 
500, 250, or 0 mg flavonoids 
(placebo)
Mood assessment, Cognitive 
Drug Research Battery 
measuring working memory, 
episodic memory, speed of 
memory and attention
No differences in cognitive performance between 
placebo and treatment groups
Massee et al. (47) 40 subjects 
(18–40 years; 16% 
males)
Cocoa bars containing 250 or 
0 mg flavanols (placebo)
Mental fatigue assessment, 
Serial Threes and Serial 
Sevens, Rapid Visual 
Information Processing Task
Improvements in serial sevens subtraction performance 
and self-reported mental fatigue in the flavanol group. 
No significant effect for cardiovascular measures
Decroix et al. (48) 12 subjects (all 
males; mean age: 
30 years)
Cocoa drinks containing 903 
and 15 mg flavanols (placebo)
Stroop task Increased cerebral blood oxygenation (NIRS) during the 
task with no significant behavioral effect
Grassi et al. (27, 28) 32 subjects
(16 males, 16 
females; mean age: 
25.3 years)
Chocolate bars containing 
520 mg (flavanol-rich) 
and 88.5 mg flavanols 
(flavanol-poor)
Psychomotor Vigilance Task, 
2-back task
Improvements in 2-back task accuracy after flavanol-rich 
treatment following a night of total sleep deprivation, 
in females. In the sleep condition, correlation between 
2-back accuracy and FMD for the whole sample
FMD, flow-mediated dilation; NIRS, near-infrared spectroscopy.
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participants showed that a single higher dose of flavanol-rich 
cocoa (516 mg) caused a significant global increase in CBF 2 h 
post-treatment (31). This result suggests an increased brain 
perfusion mediated by NO-dependent vasodilation, after cocoa 
consumption (31, 49).
In line with this result, in a recent near-infrared spectroscopy 
study, the administration of 903  mg cocoa flavanols increased 
cerebral oxygenation during the Stroop task performance in 
comparison to placebo, again suggesting increased NO-mediated 
vasodilation. Conversely, cocoa flavanols had no acute effects on 
serum BDNF levels (48). Therefore, these data support the idea 
that flavanols-induced acute changes in brain perfusion could 
underpin immediate cognitive-enhancing effects. However, 
the increased cerebral blood oxygenation was not paralleled by 
concomitant effects on cognitive performance (48). The young 
age of participants may have contributed to the lack of behav-
ioral effects. This could be particularly relevant in this study, as 
participant performed a very short, relatively simple cognitive 
task. Since cocoa has been shown to affect cognitive performance 
in healthy individuals undergoing sustained effortful cognitive 
processing (44), these results open the possibility that, at least in 
healthy young adults, a high level of cognitive demand is needed 
to uncover the subtle immediate behavioral effects of flavonoids.
Accordingly, it could be argued that flavanols may be more 
effective in sustaining performance in highly demanding contexts 
or in presence of impaired physiological functions (e.g., cardio-
vascular risk factors). In this respect, we recently evaluated, in 
healthy young subjects, the effects of acute flavanol-rich choco-
late administration on cardiovascular and cognitive function 
known to be specifically impaired by lack of sleep (27, 28). To 
this purpose, participants underwent two baseline sessions, per-
formed after undisturbed nocturnal sleep, and two experimental 
sessions, after one night of total sleep deprivation. Subjects were 
randomly assigned to consume, 90 min before each testing ses-
sion, flavonoid-rich dark chocolate (520  mg total flavanols) or 
flavonoid-poor chocolate (88.5  mg total flavanols). Cognitive 
assessment included the Psychomotor Vigilance Task, as a 
measure of behavioral alertness, and a 2-back working memory 
task. A single flavanol-rich cocoa administration was effective at 
counteracting the vascular impairment observed after a night of 
total sleep deprivation. Moreover, in the female subsample, cocoa 
flavanols also counteracted cognitive impairment specifically 
induced by sleep loss, leading to improvements in the accuracy 
measure of the working memory task. This result supports the 
idea of a specific effectiveness of cocoa flavanols in sustaining 
higher order cognitive performance during sustained effortful 
processing in healthy individuals. Interestingly, in the whole sam-
ple higher flow-mediated dilation levels, indicative of improved 
endothelial function, were related to better performance accuracy. 
Thus, although direct CBF measurements were not included, the 
results indicate that a single flavanol-rich chocolate administra-
tion could exert beneficial effects on cognitive performance 
through the capability to induce acute changes in peripheral and 
central blood flow via NO-dependent vasodilation.
Altogether, investigations on acute cognitive-enhancing effects 
of cocoa flavanols support the effectiveness of cocoa at sustaining 
cognitive performance, although with mixed results. Quantity 
and bioavailability of the consumed cocoa flavanols, together 
6Socci et al. Cocoa and Cognition
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with the length and cognitive load of the cognitive assessment, 
represent crucial factors that may significantly impact on the 
experimental outcomes.
COnCLUSiOn
In recent years, in the context of an increased interest in the 
modulatory effects of food constituents on human health, cocoa 
flavanols have been suggested to display a variety of beneficial 
biological actions, including neuroprotection and cognitive 
modulation.
At present, the limited number of studies investigating cocoa 
flavanols intake and cognitive performance has produced mixed 
results. Indeed, physiological responses to flavonoid supple-
mentation such as vasodilation, both at peripheral and central 
levels, have been consistently replicated; conversely, cognitive 
findings are not as unequivocal. When trying to account for 
such discrepancies, several methodological differences should be 
considered in dose, form, and timeframe of the cocoa flavanols 
administration, as well as in length and cognitive load of the 
experimental tasks. All these variables could have a remarkable 
impact on physiological and behavioral results and are likely to 
partly explain discrepancies among results.
Nevertheless, the evidence accumulated so far suggests that 
cocoa flavanols administration can be effective at sustaining 
cognitive performance, leading to improvements in measures 
of general cognition, attention, processing speed and memory. 
Beneficial cognitive effects of regular flavanols intake, particularly 
in patients at risk, are presumably mediated by direct neuropro-
tective actions as well as improvements in cerebrovascular and 
metabolic functions. Furthermore, acute administration of cocoa 
flavanols could result in immediate cognitive-enhancing effect, 
sustaining performance particularly in cognitively demanding 
conditions, including fatigue and sleep loss.
Altogether, research on the effects of cocoa and chocolate on 
human cognition, although at its preliminary stage, converges 
at pointing to cocoa as a new interesting nutraceutical tool to 
protect human cognition and counteract different types of cog-
nitive decline, thus encouraging further investigations. Future 
research should be addressed to the identification of sensitive 
experimental measures capable of detecting flavanol-induced 
subtle changes in cognitive performance. Moreover, the char-
acterization of appropriate dose, timing, and form of flavanols 
intervention required to reach beneficial effects in different 
populations, as well as the inclusion of fully matched placebo 
controls, are needed. Undefined remain also the effects of both 
acute and chronic administration of cocoa flavanols on chronic 
sleep deprivation and shift work, situations that may have a 
pronounced clinical impact. To elucidate immediate and long-
term neuromodulatory properties of cocoa, future investigations 
should be ideally designed to include neuroimaging techniques in 
conjunction with cognitive and physiological measures.
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